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Summary
 
Control of the rearrangement and expression of the T cell receptor 
 
a
 
 and 
 
d
 
 chains is critical for
determining T cell type. The process of 
 
d
 
 deletion is a candidate mechanism for maintaining
separation of the 
 
a
 
 and 
 
d
 
 loci. Mice harboring a transgenic reporter 
 
d
 
 deletion construct show 
 
a
 
/
 
b
 
T cell lineage–specific use of the transgenic elements. A 48-basepair segment of DNA, termed
HPS1A, when deleted from this reporter construct, loses tight lineage-specific rearrangement
control of transgenic elements, with abundant rearrangements of transgenic 
 
d
 
-deleting ele-
ments now in 
 
g
 
/
 
d
 
 T cells. Furthermore, HPS1A augments recombination frequency of extra-
chromosomal substrates in an in vitro recombination assay. DNA binding proteins recognizing
HPS1A have been identified and are restricted to early B and T cells, during the time of active
rearrangement of endogenous TCR and immunoglobulin loci. These data are consistent with
 
d
 
 deletion playing an important role in maintaining separate TCR 
 
a
 
 and 
 
d
 
 loci.
 
T
 
wo types of mature T cells possessing different tissue
distributions and apparent functions have been de-
scribed (1–9). These T cells have TCR 
 
a
 
 and 
 
b
 
 chains or
TCR 
 
g
 
 and 
 
d
 
 chains, associated with T3. Molecular cloning
and sequencing of all four TCR chains led to the discovery
of the unique localization of the TCR 
 
d
 
 chain on chromo-
some 14 in both mice and humans (10–16). The surprising
feature of this locus is that its internal coding segments, D,
J, and C
 
d
 
, are contained within the much larger TCR 
 
a
 
chain locus. This unusual feature among rearranging loci in
the immunoglobulin supergene family leads to the conun-
drum of how to regulate the recombination of the 
 
a
 
 and 
 
d
 
chain gene segments. In spite of the proximity of the two
receptors, cross-utilization of segments between the recep-
tors infrequently occurs (17, 18). These two receptor chains
are expressed in a mutually exclusive manner in different
subsets of T cells, suggesting that separate alleles do not be-
have independently. Furthermore, in 
 
g
 
/
 
d
 
 T cells, TCR 
 
a
 
chain recombinations would delete the functional 
 
d
 
 chain
and could not be allowed. These results imply a mechanism
to ensure that in 
 
g
 
/
 
d
 
 T cells, 
 
a
 
 gene rearrangement is in-
hibited and in 
 
a
 
/
 
b
 
 T cells, internal 
 
d
 
 gene segments are not
used.
During the cloning and sequencing of the human TCR
 
d
 
 chain, a novel rearrangement in early thymocytes was de-
scribed that is a candidate mechanism for discrimination
between using the TCR 
 
a
 
 versus TCR 
 
d
 
 chains. This 
 
d
 
deletion rearrangement step occurs in immature thymo-
cytes destined to become 
 
a
 
/
 
b
 
-bearing T cells. An upstream
 
d
 
-deleting element, 
 
d
 
REC, preferentially recombines with
a downstream 
 
d
 
-deleting element, 
 
c
 
J
 
a
 
, at very high fre-
quency in polyclonal human thymus (13, 19), and to a
lesser degree in murine thymus (20). This recombination
deletes all internal 
 
d
 
 coding segments, and occurs with high
frequency on both alleles in mature 
 
a
 
/
 
b
 
 T cells, suggesting
that the recombination would lead to subsequent rear-
rangements in the remaining TCR 
 
a
 
 chain locus.
A model was proposed in which 
 
d
 
 deletion is a prelimi-
nary step in the formation of TCR 
 
a
 
 chains (19, 21). Use
of the 
 
d
 
 deleting elements would be an intermediary step in
the implementation of a signal to rearrange and express
TCR 
 
a
 
 chains, thus becoming an 
 
a
 
/
 
b
 
-bearing T cell. This
model does not dictate which receptor rearranges first, 
 
a
 
 or
 
d
 
, nor in which order they rearrange. It only requires that
deletion, when it occurs, occurs before V
 
a
 
–J
 
a
 
 joining.
The model would also necessitate that 
 
d
 
-deleting element
recombinations would be restricted to the 
 
a
 
/
 
b
 
 T cell lin-
eage, for obvious reasons.
Because 
 
d
 
REC was frequently deleted on both alleles in
mature 
 
a
 
/
 
b
 
 T cells, (13, 19, 20) assessing mature T cells for
the occurrence of 
 
d
 
 deletion was unproductive. Therefore,
a 
 
d
 
 deletion transgenic reporter construct was designed to
molecularly “tag” mature 
 
a
 
/
 
b
 
 and 
 
g
 
/
 
d
 
 T cells for the oc-
currence of 
 
d
 
 deletion (21). The construct contained the 5
 
9
 
and 3
 
9
 
 
 
d
 
-deleting elements, as well as some intervening
TCR 
 
d
 
 chain J and C segments. Since the transgene was
independent of the endogenous 
 
a
 
/
 
d
 
 locus, the status of
transgenic 
 
d
 
-deleting elements could be assessed in 
 
a
 
/
 
b
 
and 
 
g
 
/
 
d
 
 T cells. Analysis of mature transgenic 
 
a
 
/
 
b
 
 T cells
demonstrated a high degree of rearrangement within this
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transgenic reporter construct, whereas mature transgenic
 
g
 
/
 
d
 
 T cells were essentially devoid of 
 
d
 
-deleting element
rearrangements (21). This lineage-specific use of 
 
d
 
-deleting
elements suggested that the machinery responsible for 
 
d
 
 de-
letion is present in developing 
 
a
 
/
 
b
 
 T cells and is absent
from the 
 
g
 
/
 
d
 
 T cell population, supporting the model for 
 
d
 
deletion in the formation of 
 
a
 
/b T cells. Furthermore, the
transgenic reporter approach allows the manipulation of
discrete DNA segments in the hope of identifying molecu-
lar mechanisms controlling the use of transgenic elements.
In this report, we extend the observations with these
transgenic molecular tags, and identify a DNA binding com-
plex and DNA recognition motif that are candidates for
controlling the lineage-specific use of the d-deleting ele-
ments.
Materials and Methods
PCR. Nonquantitative PCR was carried out essentially as
described (22) using 0.5 mg of genomic DNA per reaction tube.
The primers for all PCR reactions are listed in reference 21. Param-
eters for amplification of human dREC–Jax were 948C for 30 s,
558C for 1 min, and 728C for 30 s for 30 cycles. Internal human
dREC probe was obtained by PCR amplification of cloned plas-
mid DNA with primers internal to those used for detecting re-
arrangements of transgenic human dREC. PCR product blots,
representing 20% of reaction volume, were electrophoresed in
1% agarose gels, transferred, and hybridized as described above for
high molecular weight DNA. Quantitative PCR for dREC–Jax re-
arrangements using competitor HdREC1 was as described (21).
Transgenic Mouse Construction. The human transgenic reporter
construct  (TG)2 was identical to TG1 as described (21), except for
a 50-bp deletion within the 1.9-kb SalI to XhoI fragment, which
was subcloned into pBluescript (Stratagene Corp., La Jolla, CA)
and an oligonucleotide spanning this region, but that did not
contain the 48-bp potential signal sequence region HPS1A,
which was used to make the deletion by the oligonucleotide-
directed site-specific mutagenesis method of Kunkel (23). A se-
quence confirmed deletion mutant was isolated, and the 1.85-kb
SalI–Xho I HPS1A minus fragment was subcloned into the base
transgene construct used to make TG1. PCR was used to con-
firm that isolated transgenic constructs contained the 48-bp dele-
tion (data not shown). Transgenic founder lines were created by
injecting construct DNA into day 1 fertilized embryos by the
University of Alabama at Birmingham (Birmingham, AL) trans-
genic mouse facility.
Isolation and Expansion of g/d T Cells. g/d T cells were iso-
lated from the thymus and/or spleen of four animals at a time.
Single cell suspensions of thymocytes or splenocytes in DMEM
were isolated on 100 3 15-mm petri dishes (Fisher Scientific,
Pittsburgh, PA) that had been coated with the anti-d TCR anti-
body (403A10; supplied by Osami Kanagawa, Washington Uni-
versity, St. Louis, MO). Plates were washed to remove remaining
a/b T cells and immature T cells. DMEM with 10% fetal calf se-
rum and 50 IU/ml rIL-2 was added, and the plates were incu-
bated for 5–7 d. At this time, the cells were no longer adherent to
the plates. Cells were collected, nuclei prepared (see extracting
DNA for PCR below), 2 mg proteinase K was added, and the so-
lution incubated at 528C overnight. Extraction, precipitation, and
analysis was as described (24).
Extracting DNA for PCR. Single cell suspensions from thy-
mus or spleen were spun in eppendorf tubes at 1–2,000 g. Nuclei
were prepared by 1% triton lysis, centrifuged, and solubilized in
1% SDS. DNA was cleaned by overnight digestion with protein-
ase K and phenol extraction. Liver DNA was prepared as de-
scribed (22).
Nuclear Extract Preparation. Nuclear extracts were prepared
essentially as described (25). For human thymus, a single cell sus-
pension of thymocytes was made with a Dounce homogenizer in
nuclear extract buffer I (15 mM Hepes, pH 7.6, 10 mM KCl, 5 mM
MgCl2, 0.1 mM EDTA, 1 mM DTT, 10 mM Na2S2O5, and 2 mM
PMSF). After removing large debris and centrifugation, cells were
resuspended in 20 ml buffer I. Nuclei were prepared by passing
cells through a 27-guage needle five times with high velocity.
The nuclei were centrifuged and resuspended in 10–20 ml buffer
II (15 mM Hepes, pH 7.6, 115 mM KCl, 5 mM MgCl2, 0.1 mM
EDTA, 1 mM dithiothreitol (DTT), 10 mM Na2S205, and 2 mM
PMSF). A 10% volume of 4M (NH4)2SO4 was added to solubilize
the nuclei, and the mixture rocked gently at 48C for 30 min.
DNA was spun out at 30,000 g for 1 h at 48C. For each milliliter
of the supernatant, 0.3 g solid (NH4)2SO4 was added and the so-
lution rocked gently for 15 min at 48C. The precipitate was cen-
trifuged at 10,000 g for 20 min and resuspended in 3–5 ml of
buffer III (25 mM Hepes, pH 7.6, 50 mM KC1, 12.5 mM
MgCl2, 0.1 mM EDTA, 1 mM DTT, and 10% glycerol). The
extract was dialyzed against buffer III and stored at 2808C.
Cell Lines. Cell lines used for extract preparation were pre–T
cells RPMI 8402 (26; gift of Stan Korsmeyer, Washington Uni-
versity, St. Louis, MO), CCRF-CEM (No. CCL 119; American
Type Culture Collection, Rockville, MD), and 2052 (27; gift of
Michael Lieber, Washington University, St. Louis, MO); pre–B cell
line Nalm-6 (28; gift of Stan Korsmeyer); mature B cell line SU-
DHL-6 (29; gift of Stan Korsmeyer); HELA cells (No. CCL2;
American Type Culture Collection); and the erythroid leukemia line
MEL (gift of Tim Ley, Washington University, St. Louis, MO).
Mature B cells and T cells (unseparated tissues) were isolated as
single cell suspensions from BALB/c mice of 3–6 mo of age. Line
38B9 (27) for in vitro recombination assays was a gift of John
Kearney (University of Alabama at Birmingham, Birmingham, AL).
Mobility Shift Assay. The mobility shift assay used was a mod-
ification of Heberlein and Tjian (25). In brief, the desired probe
was end labeled with 32P, ethanol precipitated, washed extensively
to remove unincorporated nucleotides, and counted. Reactions are
performed in 1.5-ml eppendorf tubes by adding 10,000–50,000
cpm of probe (1–2 ng DNA) in 1–2 ml, 1.5 ml of 10 3 gel shift
buffer (40% glycerol, 10 mM EDTA, pH 8.0, 100 mM 2-mer-
captoethanol, 100 mM Tris, pH 8.0, 500 mM NaCl), 2.5 ml 200
ng/ml poly dI.dC, x ml extract, and 10-x ml H2O in a total vol-
ume of 15 ml. The reaction mixture was allowed to sit at room
temperature for 30 min. A 4% nondenaturing acrylamide gel was
used for fractionation of products in a running buffer of 13 TBE.
Gels were run for 1–2 h at 100–150 volts. After electrophoresis,
gels were transferred to Whatman 3-MM paper and dried under
vacuum. Autoradiography was performed for 6–12 h.
In Vitro Recombination Assay. Plasmids pLH103 and pLH104
were created by replacement subcloning the heptamer-spacer-
nonamer (h-s-n)1 of dREC into the BamHI site of pJH299 (30).
Oligonucleotides flanking the h-s-n of dREC with BamHI-clon-
able ends were used to generate BamHI-clonable DNA segments by
PCR from cloned dREC DNA. For pLH103, the 59 oligonucle-
otide was positioned to also include HPS1A in the PCR fragment;
1Abbreviations used in this paper: AMP, ampicillin; CAM, chloramphenicol;
DTT, dithiothreitol; h-s-n, heptamer-spacer-nonamer; TG, transgenic
reporter construct.93 Janowski et al.
for pLH104, the 59 primer was between HPS1A and the h-s-n.
Subcloning each PCR product into the BamHI site of pJH299
resulted in a swap of recombination signals with 23-bp spacers, and
like pJH299, pLH vectors rearrange by inversion. Each newly gen-
erated plasmid was confirmed by sequencing. The in vitro re-
combination system of Hesse et al. (27, 31) was performed essen-
tially as described. In brief, 150 ng of plasmid was introduced into
2052 or 38B9 by osmotic transfection using dextran sulfate for 5
min at 378C. Transfected cells were washed and then allowed to
grow for 48 h in DMEM with 10% FCS for 2052 or RPMI with
20% FCS for 38B9, and then the plasmid DNA was harvested by
alkaline lysis as described (32) except that the precipitation step
after addition of acetate solution III was extended to 60 min. Before
transforming into bacteria for selection, the plasmids were di-
gested with DpnI to ensure that only the plasmids that actually rep-
licated within the mammalian cells were tabulated (27). The DpnI
digested plasmids were electroporated into DH5a cells using a ma-
nipulator (BTX Electrocell Manipulator 600; BTX, San Diego,
CA) at the following settings: T 5 2.5 kV/resistance high voltage,
R5 (129 ohm), S 5 1.3 2 1.5 kV, C not used in this mode, cu-
vette gap was 1 mm. 1–10% of the transformation mixture was
plated onto 100 mg/ml ampicillin (AMP) LB plates, and the re-
mainder of the transfection mixture was plated onto 100 mg/ml
ampicillin 1 11 mg/ml chloramphenicol (AMP–CAM) LB plates.
Colonies were counted after 24 h from the AMP plates and 48 h
from the AMP–CAM plates. Rearrangement frequencies were
tabulated by comparing the number of replicated, unrearranged
plasmids (AMP plates) to replicated, rearranged plasmids (AMP–
CAM plates). To confirm that the colonies appearing on the
AMP–CAM plates were true recombinants, 51 of pLH104 and
69 of pLH103 AMP–CAM–resistant colonies were sequenced.
88% of pLH104 AMP–CAM colonies and 74% of pLH103
AMP–CAM colonies were found to be true rearrangements. The
AMP–CAM data in Table 4 has been adjusted by, and the statisti-
cal analysis reflects, the estimated number of recombinants based
upon the sequencing results. Based upon the estimated frequency
of rearrangements of 88 and 74%, respectively, and the number of
rearrangements sequenced, we have 90% confidence of ,10% er-
ror in the estimated rearrangement frequency.
Statistical Analysis. To assess the effect of cell type and plas-
mid type on rearrangement rate, logistic regression was used. The
appropriateness of the model is established by likelihood ratio test
(P 5 10232) and that both plasmid type and cell type are signifi-
cant factors in the model (P 5 8 3 10229 and P 5 3 3 1025, re-
spectively). From this model it was found that plasmid pLH103 is
2.90 times more likely to rearrange than plasmid pLH104 (95%
C-I for odds ratio 2.40–3.49) and B cells are 1.47 times more
likely to rearrange than T cells (95% C-I for odds ratio 1.23–
1.76). Statistical analysis of Table 3 for TGl and TG2 T cells pop-
ulations with sample sizes of two and three, respectively, is not
appropriate.
Results
Identification of a DNA-binding Protein Recognizing HPS1A.
One possible mechanism for regulating lineage-specific use
of the d-deleting elements would be control of the process
by sequence-specific DNA binding proteins. Any such
protein(s) would be responsible for recognizing DNA ele-
ments near dREC, and, by DNA–protein or protein–pro-
tein interactions, regulate the use of dREC. Evidence for
the role of any such protein(s) in d deletion would be con-
firmed by constructing a second transgene identical to TG1
(21), but lacking the DNA recognition sequence.
A candidate region for controlling lineage specificity in
TG1 was discovered by first comparing sequences between
human and murine dREC. The rationale was to search for
areas of high DNA homology between dRECs, and then
look for DNA binding proteins in the developing T cells of
the thymus. Two areas of very high sequence homology,
outside of the h-s-n canonical recombination motif, were
noted 59 and 39 to the recombination signal (Fig. 1 a; 20).
Nuclear extracts from murine thymus were used as probes
to determine reactivity by mobility shift assay to both re-
gions. DNA binding proteins were found in murine thy-
mus to a 97-bp upstream region, designated HPS1, that is
not detected in mature T cells of the spleen, nor in a HeLa
cell nuclear extract (Fig. 2 a, arrow).
The 97-bp segment, HPS1, is underlined in Fig. 1 a.
Two areas of near identity are seen within this region of
DNA, HPS1A and HPS1B (Fig. 1 b). Each segment, 48 bp
for HPS1A and 36 bp for HPS1B, was used as a probe for
mobility shift assay and as cold competitor during a mobil-
ity shift assay with the whole 97-bp segment as probe. In
Fig. 2 c, the 48-bp segment recognizes a similar complex in
thymic extracts, as did the 97-bp segment. The 36-bp seg-
ment failed to detect any specific DNA binding proteins
(data not shown). In addition, Fig. 2 d demonstrates that
the reactivity in this 97-bp stretch of DNA has been local-
ized to the 48 most 59 bases of HPS1, termed HPS1A, by
mobility shift competition assay. When using the 48 mer as
cold competitor, the reactivity localized to the 97-bp seg-
ment was abolished. In contrast, when the 36-bp HPS1B
segment was used as a cold competitor, essentially all reac-
tivity to HPS1 remained.
DNaase footprinting analysis using a 230-bp segment of
DNA containing HPS1A indicated that the area protected
within this 48 mer was roughly 24 bp (Fig. 1 b and data not
shown). This is a rather large footprint for a single DNA
Figure 1. Sequence of human
and murine dREC. (a) Compari-
son of human dREC and murine
dREC1. Human sequence is
shown on the top line, murine
sequence on the bottom. Verti-
cal lines represent identity be-
tween the two sequences; dashes
represent gaps in the sequence
placed by the analysis software
for better fit. The canonical h-s-n
recombinase recognition motif
is boxed and labeled. The dark
underlines outline the two areas
of z80% identity between hu-
man and mouse, HPS1 and
HPS2, respectively. (b) HPS1 has
been broken into the two areas
HPS1A and HPS1B. Human se-
quence is on the top, murine sequence on the bottom. The bracket out-
lines the area of HPS1A that is protected during DNAse I footprinting
(footprint not shown). These sequence data are available from EMBL/
GenBank/DDBJ under accession numbers Y13607 and Y13608.94 d-deleting Element Transgenic Reporter Construct
binding protein, suggesting this might be a multimember
complex.
HPS1A Recognizing Proteins Are Found only in Lymphoid
Cells and Tissues. To determine if the protein binding
complex was restricted to the T cell lineage, mobility shift
analysis was performed on several different cell types. Table 1
summarizes this data. It appears that the DNA binding com-
plex recognizing HPS1A is present in pre–T cells (8402,
CEM, and 2052) and pre–B cells (Nalm-6). Proteins rec-
ognizing the 48-bp segment were not found in mature B
or T cells (spleen and SU-DHL-6), HeLa cells, or the
erythroid leukemia line, MEL.
Constructing d-deleting Element TG2. Results from TG1
strongly suggested that regulatory signal sequences around
dREC, if they exist, must be contained within the rela-
tively small 1.9-kb DNA segment containing human
dREC (Fig. 3 a; 21). Because of its proximity to the h-s-n
and its temporal restriction to early T cells, HPS1A became
the prime candidate for a region controlling lineage-spe-
cific use of d-deleting elements. In an attempt to determine
if HPS1A is important in the d deletion process, TG2 was
assembled using oligonucleotide-directed site-specific mu-
tagenesis. The 1.9-kb SalI–XhoI dREC-containing frag-
ment in Fig. 3 b was mutated to delete the 48-bp segment,
HPS1A (black box). The newly generated 1.85-kb mutant
fragment was ligated into the base construct (Fig. 3 a) to
make TG2. TG2 was injected by the University of Ala-
bama at Birmingham (Birmingham, AL) Transgenic Facil-
ity and seven founder lines containing the construct were
created. All seven lines had expected transgenic bands by
Southern analysis, and ranged in copy number from 2 to 20
copies (data not shown). The estimated copy number of
each transgene is indicated in Table 2.
TG2 Animals Have dREC Recombinations in Both a/b and
g/d T Cells by PCR. DNA was isolated from the thymus,
spleen, and liver of all seven transgenic lines. None of the
transgenic lines of TG2 contain detectable rearrangements
by Southern blot analysis, even when the lanes are over-
loaded (data not shown). However, PCR performed on
the same DNA sources easily detected dREC–cJa and
dREC–ja56–60 recombinants in 7/7 TG2 lines (Fig. 4 and
Table 2). As was noted in TG1, dREC 39 d-deleting ele-
ment recombinations are detected within liver DNA in
those lines that have consistent dREC recombinations in
thymus and spleen DNA. The likely source for these re-
Figure 2. Mobility shift analy-
sis for DNA binding proteins
recognizing sequences around
dREC. (a) Mobility shift analy-
sis defining a protein complex,
unique to the thymus (arrow),
recognizing the upstream ho-
mology region HPS1. (b) Mobil-
ity shift gel using the down-
stream homology region HPS2
as probe. (c) Mobility shift gel
showing reactivity of the identi-
fied DNA complex from thymus
to the 48-bp subsegment HPS1A
(arrow). (d) Competitive mobility
shift assay using the 97-bp seg-
ment HPS1 as probe. Extracts
used from thymus, spleen, and
HeLa cells were crude and unpu-
rified.
Table 1. Cell Line and Tissue Survey for
HPS1A-binding Proteins
Present
Thymus
Absent
Spleen
8402 HeLa
CEM Su-DHL-6
2052 MEL
Nalm-6
Figure 3. Schematic representation of the d deletion transgenic constructs. (a) Map of TG1. The vertical bars represent cloning sites in the construction
of TG1 (21). (b) Magnification of the 1.9-kb SalI–XhoI fragment of TG1. The black box represents the 48-bp segment HPS1A, the region of DNA de-
leted to make TG2.95 Janowski et al.
combinants is contamination from circulating blood T
cells.
In contrast to TG1, dREC–cJa and dREC–Ja56–60 rear-
rangements are detected in the g/d populations of 7 out of
7 TG2 lines by PCR analysis (Fig. 4 and Table 2). It thus
appears that the use of d-deleting elements has been signifi-
cantly altered in the construct that has deleted the 48-bp
segment just 59 to dREC.
Quantitative PCR Confirms Altered Use of dREC in TG2
Lines. Although the presence of dREC recombinants in
g/d T cells of TG2 by noncompetitive PCR and the unde-
tectable dREC recombinants in TG2 a/b T cell popula-
tions by Southern blot (data not shown) suggested altered
transgenic dREC use in TG2 lines, these assays did not in-
dicate the extent of the alteration. To better elucidate the
differences between transgenic constructs, quantitative PCR
was used to investigate dREC rearrangements. A competitor
containing dREC and several Ja segments was constructed
(21) and used with the enzyme immunoassay procedure
described (33). IL-10 primers of construct pQPCR.MCC7
(33) are situated within a single exon of that gene and serve
as a control for the number of alleles within each DNA prepa-
ration. Since the seven transgenic lines showing consistent
dREC recombinations appeared to be identical, only three
lines were used for quantitative PCR on tissues and puri-
fied g/d T cell populations (lines 4-4, 5-5, and 6-1). The
thymus was used for a relatively pure population of T cells,
predominantly a/b T cells. Table 3 summarizes the TG2
lines quantitative rearrangement data, and indicates that
dREC recombinations are more frequent in the TG2 g/d
Table 2. dREC TG2 Recombination Results by PCR
Clone
Estimated transgene
copy number
Rearrangement
a/bg / d
3-1 20 11 1
4-4 15 11 1
4-5 10 11
5-4 10 11 1
5-5 5 11 1
6-1 20 11
6-3 10 11 1
Figure 4. Southern blot of
PCR products from (a) dREC to
cJa recombinations in TG2 (4-4
and 6-3) and TG1 (22) lines
probed with an internal human
dREC probe and (b) photograph
of ethidium bromide–stained gel
PCR products primed with germ-
line human dREC primers. P,
primers only; M.T., murine thy-
mus nontransgenic DNA nega-
tive control; H.T., human thy-
mus DNA positive control; T,
polyclonal thymus DNA; S,
polyclonal spleen DNA; gd, po-
lygonal g/d T cell DNA. Note that the diminished reactivity in 63 gd
lane in part a corresponds to less ethidium reactivity on 63 gd DNA in
part b. Ethidium bromide reactivity for TG1 line 22 DNA was reported
in reference 27.
Table 3. Quantitation of In Vivo Transgenic Rearrangements by PCR
dREC–Ja57 dREC–cJad REC–Ja58 Total dREC rearrangements
TG1
14 Thymus 0.1 6 0.08 0.2 6 0.05 56 6 23 56
14 g/d, 0.3 6 ND ,0.3 6 ND 0.3 6 0.1 0.3
Ratio a/b:g/d 188
22 Thymus 6 6 2 25 6 7 294 6 74 325
22 g/d  ,0.3 6 ND 2 6 0.3 1 6 0.4 3
Ratio a/b:g/d 108
TG2
4-4 Thymus 0.6 6 0.2 0.4 6 0.3 13 6 31 4
4-4  g/d 12  6 ND 4 6 1 50 6 56 6
Ratio  a/b:g/d 0.2
5-5 Thymus 3 6 0.4 36 6 13 74 6 19 113
5-5 g/d 0.5 6 0.5 5 6 3 23 6 52 9
Ratio  a/b:g/d 4
6-1 Thymus 0.1 6 0.05 0.1 6 0.04 2.3 6 0.4 3
6-1 g/d 6 6 27  6  0.6 75 6 58 8
Ratio  a/b:g/d 0.03
All values normalized to 100,000 copies of IL-10 DNA.96 d-deleting Element Transgenic Reporter Construct
T cell population when compared to TGl lines 14 and 22.
The ratio of recombinations found in T cells of TG2 lines
4-4, 5-5, and 6-1 were 0.03–4-fold more frequent in the
thymic T cell population than in the purified g/d T cell
population. Conversely, in the TG1 lines, the ratio of
dREC recombinations in a/b versus g/d T cells ranges
from 109 to 186. This recombination ratio represents an
z100-fold lower a/b:g/d recombination frequency ratio
in TG2 T cells than that seen in TG1 lines 14 and 22 T cells.
In comparing the numbers from both TG1 and TG2 popu-
lations, the major change was the increased frequency of
transgenic dREC recombinations in TG2 g/d T cells from
,3 dREC rearrangements/100,000 alleles in TG1 lines to
.25 dREC rearrangements/100,000 alleles in TG2 lines.
The data contained in Table 3 also suggests an altered use
of transgenic dREC in polyclonal a/b T cell populations
in TG2 lines compared to TG1 lines. On average, there are
more rearrangements in TG1 thymus (190/100,000 alleles)
versus TG2 thymus (33/100,000 alleles). This apparent re-
duced incidence of quantifiable rearrangements in TG2 a/b
T cells (zfivefold decrease compared to TG1 lines) and the
absence of detectable rearrangements in TG2 DNA by South-
ern blot analysis (data not shown) suggested that the DNA
segment HPS1A also functions as an enhancer of recombi-
nation in a/b T cells. However, due to probable inser-
tional effects within both transgenic lines, leading to a wide
range of dREC recombinations within these lines (note the
difference in thymic dREC recombinations in TG2 lines
4-4, 5-5, and 6-1), z20–30 different founders for each
construct would need to be analyzed to reach statistical sig-
nificance. To circumvent the need for multiple transgenic
founder lines, we used the in vitro recombination system of
Hesse et al. (31) to follow the effects of HPS1A on recom-
bination.
In Vitro Analysis of Rearranging Substrates Confirms a Lower
Recombination Frequency when the DNA Segment HPS1A Is
Absent. Plasmids pLH103 and pLH104 were generated
from the base construct pJH299 (30) by the addition of the
dREC h-s-n with and without the DNA segment HPS1A
(Fig. 5). These rearranging substrates were independently
transfected into the putative a/b T cell line 2052 (27) and
the B cell line 38B9 (27) and analyzed for rearrangements
(see Materials and Methods). Table 4 is a compilation of
four separate experiments of each plasmid into both the T
and B cell lines. Construct pLH103 (containing HPS1A) con-
sistently produces more rearrangements in both cell lines, when
compared to construct pLH104 (significant to P ,,0.00001).
The threefold increase in recombinations seen with pLH103
is very close to the zfivefold increase in recombinations
Figure 5. Schematic representation of the rearranging substrates pLH103
and pLH104. The plasmid pJH299 was modified to accept the dREC
h-s-n with (pLH103) and without (pLH104) the adjacent HPS1A DNA
segment.
Table 4. Quantitation of In Vitro Rearrangements
Cell line Colony status
Plasmid
Fold increase
pLH103/pLH104 pLH103 (1 HPS1A) pLH104 (2 HPS1A)
38B9 No. recombined* (AMP–CAM) 185 75
(pre–B) Total Dpnl-resistant colonies (AMP) 34,407 55,353 Combined
2.90‡
2052 No. recombined* (AMP–CAM) 119 98
(pre–T) Total Dpnl-resistant colonies (AMP) 19,151 32,455
*69 pLH103 colonies and 51 pLH104 colonies were sequenced to obtain an estimate of the number of true recombinants (see Materials and Meth-
ods).
‡Significant by logistic regression model to P ,,0.00001.97 Janowski et al.
seen when comparing a/b T cells in TG1 lines to a/b T
cells from TG2 lines (Table 3). Curiously, the B cell line
38B9 rearranges the substrates more frequently than the T
cell line 2052. Nonetheless, the presence of HPS1A on
nonchromosomal rearranging constructs in both T and B
cells increases recombination by zthreefold.
Discussion
The unique positioning of the d locus within the a
TCR locus has clear implications for T cell lineage devel-
opment. Mechanisms must exist to ensure the separation
and control of recombinations within this combined locus.
Two models have been proposed for a versus d receptor
development: (a) precommitment of T cell precursors, and
(b) ordered rearrangement of receptors. Precommitment is
defined as choosing which T cell type, a/b or g/d, to be-
come by some unknown mechanism before rearranging
the receptor genes (34–37). This choice could take place at
any time before commencing TCR rearrangement, includ-
ing the earliest stages of development in the bone marrow
or fetal liver. This model implies that a signal for particular
T cell lineage is generated, by other unknown mechanisms,
and then implemented by controlling the use of TCR a or
d chain rearrangement and expression.
The second hypothesis, the ordered rearrangement hy-
pothesis, states that control of the a/d locus occurs through
an ordered rearrangement of the d chain first, and, if failed
or inappropriate, then commencing a chain recombination
(38, 39). This model implies that functional d chain rear-
rangement and expression essentially precludes a chain re-
combination. Recent evidence from several groups favors
this ordered rearrangement hypothesis (40, 41). Data pre-
sented seems to demonstrate a high degree of d chain rear-
rangements have occurred in a/b T cells, a finding that is
incompatible with a precommitment model.
At present, it is not clear how the data supporting each
of these models will be reconciled. It is undoubtedly a
complex process for choosing receptor type, and more data
is needed before precise mechanisms can be defined. How
then, does d deletion fit into these paradigms? Several
pieces of data suggest d deletion plays a central role in the
process of maintaining separate a and d receptors. (a) The
frequency of d deletion, most notable in human thymus, is
consistent with d deletion often occurring on both alleles
in cells destined to rearrange TCR a chains (19). (b) The
high degree of evolutionary conservation in location, se-
quence identity, and apparent function indicates a signifi-
cant role for d deletion in T cell development (20). (c) The
maintenance of lineage specificity for d deletion in the first
transgenic construct implies tight regulatory control over the
use of d-deleting elements (21). (d) A discrete population of
developing CD3, CD4, CD8 negative thymocytes contain-
ing dREC–cJa recombinations but not Va–Ja joining im-
plies that d deletion occurs before TCR a chain recombi-
nation (21).
Corroborating data for d deletion as an antecedent to
Va–Ja joining has been reported (42). In this in vitro sys-
tem, immature thymocytes progress to undergo dREC re-
arrangements before forming functional TCR a chains.
However, none of this data proves that d deletion occurs
before Va–Ja joining on the same allele, in individual cells.
To try and understand the potential role of d deletion in
the formation of T cell receptors, we developed a transgenic
reporter construct for the detection of d-deleting element
recombinations. This transgene was designed to molecularly
“tag” cells having undergone d deletion, for subsequent
analysis within mature T cell populations. The model of d
deletion implies that use of deleting elements would be re-
stricted to the a/b T cell population. If d deletion was a
random phenomenon, then rearrangements would be ex-
pected in all T cell lineages. Human TG1 displayed a remark-
able degree of lineage specificity for the use of the d-delet-
ing elements (Table 3), as predicted by the model (21). This
data strongly suggests that d deletion is involved, in some
fashion, with developing a/b T cells. It further implies that
tight regulatory control of d deletion in g/d T cells exists,
even on random integration of transgenic d-deleting ele-
ments. The data also suggested that DNA segments mediat-
ing the tight control of d deletion would be contained
within the transgene reporter construct, TG1.
The next obvious step was to define the molecular basis
for lineage-specific control of this process. The identifica-
tion of a DNA binding protein, specific to a region near
dREC and restricted to rearranging cells, allowed the pre-
cise targeting of a DNA region that might be responsible
for this lineage-specific control of transgenic elements. When
TG2 was designed, one of three outcomes was anticipated:
(a) no differences noted between TG1 and TG2, (b) loss of
all or most recombination in a/b T cells of TG2, or (c) loss
of lineage specificity with recombination seen in both a/b
and g/d T cell populations of TG2. Either the loss of re-
combination or the loss of lineage specificity would sub-
stantiate the presence of signal sequences for control of d
deletion within the 48-bp segment, HPS1A, whose dele-
tion was the only change between the two transgenic con-
structs. We report here the loss of tight lineage specificity
for d deletion, with frequent rearrangements present in
TG2  g/d T cells. Moreover, the TG2 transgenic construct
in a/b T cells also demonstrates alterations when HPS1A is
removed, with a decreased frequency of transgenic dREC
rearrangements (an zfivefold decrease in peripheral T cells
[Table 3] confirmed by in vitro recombinatorial analysis
[Table 4]). Therefore, we propose that the 48-bp DNA el-
ement, HPS1A, is a recognition motif for a DNA binding
protein complex that controls recombination at dREC.
Two lines of evidence supports HPS1A’s role in d dele-
tion. As mentioned above, the removal of this recognition
sequence in TG2 resulted in transgenic dREC rearrange-
ments in both a/b and g/d T cells, and appears to alter the
frequency of dREC recombinations in the a/b T cell sub-
sets, and more importantly in in vitro recombination sys-
tems. This data suggests that this DNA motif has two func-
tions: in a/b T cells, HPS1A seems to promote and
facilitate recombination; in g/d T cells it seems to inhibit
dREC recombination (see below).98 d-deleting Element Transgenic Reporter Construct
Secondly, the presence of specific DNA binding proteins
recognizing HPS1A is limited to early lymphoid lineages
(pre–B and pre–T cells, Table 1) where active recombina-
tion of TCR genes is occurring (27). It is interesting that
proteins recognizing HPS1A are also found in pre–B cells.
Precedent for mechanisms separating two independent re-
arranging loci has been suggested between k and l immu-
noglobulin light chains. In this system, k recombination
precedes l. When failed or inappropriate k rearrangement
has occurred, an element termed the k-deleting element in
humans (43–45) or RS in the mouse (41, 46, 47), deletes
the Ck segment and l rearrangement commences. The de-
leting element resides z10 kb 39 to Ck and is composed of
the canonical recognition sequence of the putative recom-
binase complex, a h-s-n motif. In l producing B cells, k
deletion has occurred on both k alleles and appears to occur
before the rearrangement and expression of l light chains in
most l-producing B cells. A preliminary search around the
k-deleting element and RS sequences has not revealed any
homology with dREC or HPS1A (data not shown). A more
extensive search is currently underway.
The described effects of HPS1A on recombination of
dREC are compatible with either positive or negative reg-
ulation. For example, in a/b T cells, the presence of pro-
teins recognizing HPS1A may actively promote recombi-
nation of dREC, and the absence of such proteins in g/d
T cells would be the basis for lineage specificity. This pro-
motion of recombination, presumably through protein–
protein interaction with the recombinase complex, would
focus recombination at dREC and facilitate dREC rear-
rangements (we prefer “facilitation” to “enhancement” be-
cause of the relatively modest [z60–80%] decrease in
transgenic  dREC rearrangements when HPS1A is deleted).
The positive regulatory model would have an absolute re-
quirement for the presence of HPS1A-recognizing proteins
before recombination could occur because of the scarcity
of dREC rearrangements detected in the g/d population of
TG1 (Table 3). If such a model were true, it would imply
another DNA segment, other than the h-s-n of immuno-
globulins and T cell receptors, is directing a recombinase
mediated event. Two other such sites, termed KI and KII,
were recently described in the murine k light chain locus
(48). Mutation of both elements resulted in an z80% de-
crease in rearrangements into the cis k chain locus. Interest-
ingly, the decrease seen by removal of HPS1A closely matches
the decrease seen when both k locus elements are mutated.
However, a comparison of DNA binding regions for KI,
KII, and HPS1A shows no significant homology (data not
shown) suggesting the two processes are not related.
Conversely, recombination of dREC may be a default
pathway in T cell development, and proteins inhibiting this
recombination in g/d T cells could result in the mainte-
nance of lineage specificity. The default pathway in this
negative regulatory model would need to be highly effi-
cient to explain the high degree of dREC recombination
found in a/b T cells (21). In addition, removal of a DNA
recognition sequence (HPS1A) in the default pathway would
also be required to effect the efficiency of dREC recombi-
nation, to explain the frequency change of transgenic dREC
rearrangements seen in in vitro recombination assays and
thymic a/b T cells of TG2 (Tables 3 and 4).
Although the data is not conclusive, we favor a model in
which both positive and negative regulation occurs in the
different lineages. The signal to become an a/b T cell
would generate proteins that would interact with HPS1A,
thereby promoting dREC recombinations leading to d de-
letion. The signal to become a g/d T cell would result in
the generation of proteins that would interact with HPS1A
and prevent rearrangements involving dREC. It is also pos-
sible that positive or negative regulation of dREC recom-
bination is one or more steps removed from interaction
with HPS1A, protein–protein interactions with HPS1A
binding proteins mediate the desired effect.
Nonetheless, the data from TG2 strongly suggests that
HPS1A is the focal point for a signal that directs lineage-
specific use of the d-deleting elements. Understanding this
signal will require the isolation, partial sequencing, and
cloning of the DNA binding proteins recognizing HPS1A.
We have successfully isolated the 70-kd member of this
complex (data not shown). Partial amino acid sequencing
has revealed no homology to known proteins, and we are
actively pursuing the cloning of its gene.
d deletion seems to play a central role in the process of
maintaining separate TCR a and d loci. The evolutionary
presence of such seemingly redundant systems for deleting
d coding segments (Va to Ja joining would also delete
d-coding segments) implies the choice between a or d recep-
tors needs to be tightly regulated, and that a complex inter-
action between inhibition and induction of recombination
is involved in the process of choosing receptor type. For
instance, the induction of d chain rearrangement in g/d
T cell precursors also requires the inhibition of Va to Ja
joining or the functional d chain would be deleted. There-
fore, the a/d locus seems to be the focal point for the sepa-
ration of a/b and g/d T cell lineages. Control of the rear-
rangement process within this combined locus appears to
be the implementation of signals for determination of T cell
type. Understanding d deletion may lead to a description of
the molecular events underlying T cell lineage commitment.
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